Literature DB >> 19361989

Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability.

Michael J Waring1.   

Abstract

Analysis of a large, structurally diverse Caco-2 permeability dataset using a variety of statistical techniques suggests that logD and molecular weight are the most important factors in determining the permeability of drug candidates. The limit for logD is shown to be dependent on molecular weight. These limits are shown to be potentially superior to current guidelines in increasing the chances of finding highly permeable compounds. When combined with suggested upper limits for lipophilicity suggested in the literature based on the avoidance of toxicology and other adverse effects, this helps define a lipophilicity range that is optimum for drug candidates.

Mesh:

Substances:

Year:  2009        PMID: 19361989     DOI: 10.1016/j.bmcl.2009.03.109

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

Review 1.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Authors:  Michael M Hann; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

Review 2.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

3.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes.

Authors:  Travis T Wager; Ramalakshmi Y Chandrasekaran; Xinjun Hou; Matthew D Troutman; Patrick R Verhoest; Anabella Villalobos; Yvonne Will
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

4.  Gramicidin-based fluorescence assay; for determining small molecules potential for modifying lipid bilayer properties.

Authors:  Helgi I Ingólfsson; R Lea Sanford; Ruchi Kapoor; Olaf S Andersen
Journal:  J Vis Exp       Date:  2010-10-13       Impact factor: 1.355

5.  Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants.

Authors:  Shin-Ichiro Hattori; Hironori Hayashi; Haydar Bulut; Kalapala Venkateswara Rao; Prasanth R Nyalapatla; Kazuya Hasegawa; Manabu Aoki; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 6.  An analysis of the attrition of drug candidates from four major pharmaceutical companies.

Authors:  Michael J Waring; John Arrowsmith; Andrew R Leach; Paul D Leeson; Sam Mandrell; Robert M Owen; Garry Pairaudeau; William D Pennie; Stephen D Pickett; Jibo Wang; Owen Wallace; Alex Weir
Journal:  Nat Rev Drug Discov       Date:  2015-06-19       Impact factor: 84.694

Review 7.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

8.  A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.

Authors:  Kehinde F Omolabi; Emmanuel A Iwuchukwu; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2021-01-09       Impact factor: 1.810

9.  Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.

Authors:  ThanhTruc Pham; Madeline Walden; Christopher Butler; Rosario Diaz-Gonzalez; Guiomar Pérez-Moreno; Gloria Ceballos-Pérez; Veronica Gomez-Pérez; Raquel García-Hernández; Henry Zecca; Emma Krakoff; Brian Kopec; Ogar Ichire; Caden Mackenzie; Marika Pitot; Luis Miguel Ruiz; Francisco Gamarro; Dolores González-Pacanowska; Miguel Navarro; Amy B Dounay
Journal:  Bioorg Med Chem Lett       Date:  2017-07-11       Impact factor: 2.823

10.  Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.

Authors:  Joshua Schwochert; Yongtong Lao; Cameron R Pye; Matthew R Naylor; Prashant V Desai; Isabel C Gonzalez Valcarcel; Jaclyn A Barrett; Geri Sawada; Maria-Jesus Blanco; R Scott Lokey
Journal:  ACS Med Chem Lett       Date:  2016-06-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.